These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5880875)

  • 1. Presence of alpha-methyl-DOPA metabolites in heart and brain of guinea pigs treated with alpha-methyl-tyrosine.
    Maître L
    Life Sci; 1965 Dec; 4(23):2249-56. PubMed ID: 5880875
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of the optical isomers of alpha-methyl-p-tyrosine upon brain and heart catecholamines in the mouse.
    Porter CC; Totaro JA; Burcin A; Wynosky ER
    Biochem Pharmacol; 1966 May; 15(5):583-90. PubMed ID: 5961435
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of alpha-methyltyrosine on brain catecholamines and conditioned behavior in guinea pigs.
    Moore KE
    Life Sci; 1966 Jan; 5(1):55-65. PubMed ID: 5933656
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of alpha-methyldopa and alpha-methyl-m-tyrosine on the mobilization of free fatty acids.
    Stock K; Westermann E
    Experientia; 1964 Sep; 20(9):495-6. PubMed ID: 4379187
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of alpha-methyldopa, alpha-methyldopamine, and alpha-methyl-norepinephrine on the norepinephrine content of the isolated heart.
    Philippu A; Schümann HJ
    Life Sci; 1965 Nov; 4(21):2039-46. PubMed ID: 5866620
    [No Abstract]   [Full Text] [Related]  

  • 6. Saligenin analogs of l-DOPA and dl-alpha-methyl-DOPA.
    Atkinson M; Hartley D; Lunts LH; Ritchie AC
    J Med Chem; 1974 Feb; 17(2):248-9. PubMed ID: 4809259
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the mechanism of adrenergic action of alpha-methyl-m-tyrosine].
    Gessa GL; Vargiu L; Crabai E
    Boll Soc Ital Biol Sper; 1966 Apr; 42(7):359-61. PubMed ID: 5949373
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the effects of alpha-methyl-dopa on the pyrocatecholamine content in guinea pig organs].
    Schümann HJ; Grobecker H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Jun; 251(1):48-61. PubMed ID: 4222456
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive effects of alpha-methylated catecholamine analogues in the rat.
    Brunner H; Hedwall PR; Maître L; Meier M
    Br J Pharmacol Chemother; 1967 May; 30(1):108-22. PubMed ID: 6039967
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of alpha-methyldopa and alpha-methyl-m-tyrosine on the amount of noradrenaline in the heart and brain of irradiated rats.
    Stepanović SR; Nikolić JV; Varagić VM
    Strahlentherapie; 1977 Jun; 153(6):426-30. PubMed ID: 877979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subcellular distribution of pyrocatecholamines in heart and adrenal glands of guinea pigs after preliminary treatment with l-alpha-methyldopa].
    Grobecker H; Schümann HJ
    Experientia; 1966 Jan; 22(1):22-3. PubMed ID: 5915124
    [No Abstract]   [Full Text] [Related]  

  • 12. Central dopamine and noradrenaline receptor activity of the amines formed from m-tyrosine, alpha-methyl-m-tyrosine and alpha-methyldopa.
    Andén NE; Butcher SG; Engel J
    J Pharm Pharmacol; 1970 Jul; 22(7):548-50. PubMed ID: 4395068
    [No Abstract]   [Full Text] [Related]  

  • 13. The depletion of norepinephrine-3H from heart by alpha-methyl-m-tyrosine. A novel and convenient method for assaying the inhibition of aromatic amino acid decarboxylase in vivo.
    Creveling CR; Daly JW; Witkop B
    J Med Chem; 1966 May; 9(3):284-6. PubMed ID: 5960888
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical and pharmacological effects of iodo-tyrosines; relation to tyrosine hydroxylase inhibition in vivo.
    Spector S; Mata RO; Sjoerdsma A; Udenfriend S
    Life Sci; 1965 Jul; 4(13):1307-11. PubMed ID: 5849271
    [No Abstract]   [Full Text] [Related]  

  • 15. On the norepinephrine replacement by alpha-methyl-norepinephrine in the rat heart after treatment with alpha-methyl-DOPA.
    Maître L; Staehelin M
    Experientia; 1967 Oct; 23(10):810-1. PubMed ID: 6076302
    [No Abstract]   [Full Text] [Related]  

  • 16. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
    Rech RH; Borys HK; Moore KE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of DL-3-(5-benzimidazolyl)-2-methylalanine on brain and heart catecholamines-I. Depleting effects.
    Zenker N; Morgenroth VH; wright J; King JW; Arnett CD
    Biochem Pharmacol; 1976 Mar; 25(5):585-9. PubMed ID: 8054
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression, by alpha-methyl-DOPA and alpha-methyl-p-tyrosine, of the anti-inflammatory action of aminopyrine.
    Jaques R
    Helv Physiol Pharmacol Acta; 1965; 23(3):311-4. PubMed ID: 5860614
    [No Abstract]   [Full Text] [Related]  

  • 19. Modification of the effects of tranquilizers in animals treated with alpha-methyl-l-tryrosine.
    Menon MK; Dandiya PC; Bapna JS
    J Pharmacol Exp Ther; 1967 Apr; 156(1):63-9. PubMed ID: 6023601
    [No Abstract]   [Full Text] [Related]  

  • 20. Ascorbic acid: effect of high doses on brain and heart catecholamine levels in guinea-pigs and rats.
    Dashman T; Horst D; Bautz G; Kamm JJ
    Experientia; 1973; 29(7):832-3. PubMed ID: 4724718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.